← All trials
NCT04455503
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2020
- Primary completion
- Mar 31, 2024
- Completion date
- Jul 31, 2026
- First posted
- Jul 2, 2020
- Last posted
- Oct 19, 2020
- Enrollment
- 46
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Evaxion Biotech A/SLead sponsor
- NovotechCollaborator
- Royal Liverpool & Broadgreen University Hospitals NHS TrutsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.